SIA
BSX icon

Schear Investment Advisers’s Boston Scientific BSX Stock Holding History

Schear Investment Advisers’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Sell
36,860
-3,022
-8% -$164K 0.53% 51
2026
Q1 		$2.5M Buy
39,882
+12,370
+45% +$990K 1.1% 32
2025
Q4 		$2.62M Buy
27,512
+1,736
+7% +$170K 1.13% 27
2025
Q3 		$2.52M Buy
25,776
+233
+0.9% +$24.1K 1.12% 27
2025
Q2 		$2.74M Buy
25,543
+1,293
+5% +$131K 1.36% 20
2025
Q1 		$2.45M Buy
24,250
+1,144
+5% +$115K 1.41% 20
2024
Q4 		$2.06M Buy
23,106
+3,336
+17% +$294K 1.1% 23
2024
Q3 		$1.66M Buy
19,770
+1,727
+10% +$136K 1.03% 31
2024
Q2 		$1.39M Buy
18,043
+1,629
+10% +$119K 1% 31
2024
Q1 		$1.12M Buy
16,414
+2,010
+14% +$129K 0.9% 36
2023
Q4 		$833K Buy
14,404
+100
+0.7% +$5.34K 0.8% 42
2023
Q3 		$755K Sell
14,304
-412
-3% -$21.6K 0.81% 43
2023
Q2 		$796K Buy
14,716
+771
+6% +$40.3K 0.84% 42
2023
Q1 		$698K Buy
13,945
+112
+0.8% +$5.28K 0.83% 42
2022
Q4 		$640K Buy
+13,833
New +$599K 0.79% 46

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Schear Investment Advisers's BSX Position: Q2 2026 in Review

Schear Investment Advisers reduced its Boston Scientific (BSX) stake by 7.6% in Q2 2026, selling an estimated $164K and leaving 36,860 shares worth $1.57M. The position accounts for 0.53% of the portfolio, ranked #51.

Schear Investment Advisers first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.74M in Q2 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Schear Investment Advisers held 36,860 shares of Boston Scientific worth $1.57M as of Q2 2026.
  • Schear Investment Advisers sold 3,022 Boston Scientific shares in Q2 2026, an estimated $164K.
  • Boston Scientific made up 0.53% of Schear Investment Advisers's portfolio in Q2 2026, its #51 holding.
  • Schear Investment Advisers first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
  • Schear Investment Advisers's Boston Scientific position peaked at $2.74M in Q2 2025.
  • 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Schear Investment Advisers's 13F filing for Q2 2026, filed 27 Jul 2026.